Identifying risk factors for imminent death in cancer patients with acute dyspnea

被引:33
作者
Escalante, CP
Martin, CG
Elting, LS
Price, KJ
Manzullo, EF
Weiser, MA
Harle, TS
Cantor, SB
Rubenstein, EB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Internal Med Specialties, Gen Internal Med Sect, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Div Crit Care & Anesthesia, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Ambulatory & Support Care Res Program, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Div Diagnost Radiol, Houston, TX 77030 USA
关键词
dyspnea; survival imminent death; cancer; predictive models;
D O I
10.1016/S0885-3924(00)00193-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A substantial proportion of cancer patients presenting to an emergency center (EC) or clinic with acute dyspnea survives fewer than 2 weeks. If these patients could be identified at the the time of admission, physicians and patients would have additional information on which to base decisions to continue therapy to extend life or to refocus treatment efforts on palliation and/or hospice care alone. The purpose of this study was to identify risk factors for imminent death (survival less than or equal to 2 weeks) and short-term survival (1, 3, or 6 months) in cancer patients presenting to an EC with acute dyspnea and to combine these factors into a model to help clinicians identify patients with short life expectancies. A random sample of 122 patients presenting to an EC with acute dyspnea was selected for a retrospective analysis. Data that were available to physicians during the initial EC visit included patient histories, triage and discharge vital signs, chest radiographs, and laboratory results. These variables were used in univariate and logistic regression models to develop predictive models for imminent death and short-term survival. Variables and interactions meeting a univariate criterion of P < 0.10 were included in stepwise regression by using forward and backward stepping. Models were compared with the use of Hosmer-Lemeshow statistics and receiver operating characteristics curves. Underlying cancers were 30% breast, 37% lung, and 34% other cancers. Triage respiration greater than 28/min., triage pulse greater than or equal to 110 bpm, uncontrolled progressive disease, and history of metastasis were found to be statistically significant predictors (<alpha> less than or equal to 0.05) of imminent death. Patients with uncontrolled progressive disease had a relative risk of imminent death of 21.93. Relative risks for triage respiration, pulse, and metastases were 12.72, 4.92, and 3.85, respectively. Cancer diagnosis was not predictive of imminent death but was predictive when longer time periods were modeled. It may be possible to identify patients whose death is imminent from a group of cancer patients with acute dyspnea. Some factors that predict imminent death (triage pulse and respiration) differ from those (cancer diagnosis) that predict short-term survival. Extent of disease/response to treatment is common to all models. These factors need further examination and validation. If these findings are confirmed, this quantified information can help physicians in making difficult end-of-life decisions. J Pain Symptom Manage 2000;20:318-325. (C) U.S. Cancer Pain Relief Committee, 2000.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 26 条
  • [1] TREATMENT OF INTRACTABLE DYSPNEA - CLINICAL AND ETHICAL ISSUES
    COHEN, MH
    JOHNSTONANDERSON, A
    KRASNOW, SH
    WADLEIGH, RG
    [J]. CANCER INVESTIGATION, 1992, 10 (04) : 317 - 321
  • [2] Symptom prevalence in the last week of life
    Conill, C
    Verger, E
    Henriquez, I
    Saiz, N
    Espier, M
    Lugo, F
    Garrigos, A
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (06) : 328 - 331
  • [3] Non-pharmacological intervention for breathlessness in lung cancer
    Corner, J
    Plant, H
    AHern, R
    Bailey, C
    [J]. PALLIATIVE MEDICINE, 1996, 10 (04) : 299 - 305
  • [4] Cowcher K, 1990, J Pain Symptom Manage, V5, P320, DOI 10.1016/0885-3924(90)90048-O
  • [5] CURTIS EB, 1991, PALLIAT CARE, V7, P225
  • [6] DONNELLY S, 1995, SEMIN ONCOL, V22, P67
  • [7] Escalante CP, 1996, CANCER, V78, P1314, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO
  • [8] 2-2
  • [9] Sedation for uncontrolled symptoms in a South African hospice
    Fainsinger, RL
    Landman, W
    Hoskings, M
    Bruera, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 16 (03) : 145 - 152
  • [10] CLINICAL-APPLICATION OF NEBULIZED OPIOIDS FOR TREATMENT OF DYSPNEA IN PATIENTS WITH MALIGNANT DISEASE
    FARNCOMBE, M
    CHATER, S
    [J]. SUPPORTIVE CARE IN CANCER, 1994, 2 (03) : 184 - 187